Drug intelligence / Profile preview

sodium hyaluronate + chondroitin sulfate (Alcon Inc.)

Development stage
Unknown
Lead developer
Alcon
Administration
Ophthalmic
01

Overview

Viscoat is a dispersive ophthalmic viscoelastic device (OVD) composed of a combination of 3% sodium hyaluronate and 4% chondroitin sulfate. It is primarily utilized during cataract surgery and other anterior segment procedures to protect the corneal endothelium from mechanical trauma and ultrasound energy (phacoemulsification). Unlike cohesive OVDs, Viscoat's dispersive properties allow it to adhere to and coat ocular tissues effectively, remaining in the eye during irrigation and aspiration phases of surgery. This provides continuous protection throughout the procedure, which is critical for maintaining corneal clarity and preventing endothelial cell loss. It was originally developed by Alcon.

Brand names
Viscoat
Other names
sodium hyaluronate and chondroitin sulfate

Beyond the preview

Go deeper on sodium hyaluronate + chondroitin sulfate (Alcon Inc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium hyaluronate + chondroitin sulfate (Alcon Inc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call